Edward Myles
2016
In 2016, Edward Myles earned a total compensation of $1.3M as Chief Financial Officer, Senior Vice President of Finance & Treasurer at AMAG Pharmaceuticals.
Compensation breakdown
| Bonus | $34,300 |
|---|---|
| Non-Equity Incentive Plan | $115,726 |
| Option Awards | $379,033 |
| Salary | $276,923 |
| Stock Awards | $491,600 |
| Other | $7,950 |
| Total | $1,305,532 |
Myles received $491.6K in stock awards, accounting for 38% of the total pay in 2016.
Myles also received $34.3K in bonus, $115.7K in non-equity incentive plan, $379K in option awards, $276.9K in salary and $8K in other compensation.
Rankings
In 2016, Edward Myles' compensation ranked 6,935th out of 14,075 executives tracked by ExecPay. In other words, Myles earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,935 out of 14,075 | 51st |
Division Manufacturing | 2,606 out of 5,488 | 53rd |
Major group Chemicals And Allied Products | 850 out of 1,900 | 55th |
Industry group Drugs | 654 out of 1,543 | 58th |
Industry Pharmaceutical Preparations | 518 out of 1,173 | 56th |
Source: SEC filing on April 20, 2017.
Myles' colleagues
We found five more compensation records of executives who worked with Edward Myles at AMAG Pharmaceuticals in 2016.
2016
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2016
Nicholas Grund
AMAG Pharmaceuticals
Chief Commercial Officer
2016
Frank Thomas
AMAG Pharmaceuticals
Chief Operating Officer
2016
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2016
Joseph Vittiglio
AMAG Pharmaceuticals